Psyence Biomedical Ltd. (PBM)
4.20
-0.13
(-3.00%)
USD |
NASDAQ |
Aug 24, 16:00
4.20
0.00 (0.00%)
After-Hours: 20:00
Psyence Biomedical Shareholders Equity (Quarterly) : 11.87M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2025 | 11.87M |
| September 30, 2024 | -1.255M |
| December 31, 2023 | |
| September 30, 2023 | -3.497M |
| June 30, 2023 | 1.461M |
| March 31, 2023 | 1.524M |
| December 31, 2022 | 244.66M |
| Date | Value |
|---|---|
| September 30, 2022 | 242.41M |
| June 30, 2022 | 241.64M |
| March 31, 2022 | 239.60M |
| December 31, 2021 | 236.65M |
| September 30, 2021 | -0.0545M |
| June 30, 2021 | -0.0094M |
| March 31, 2021 | 0.0182M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Sirona Biochem Corp. | -- |
| Xenon Pharmaceuticals, Inc. | 1.242B |
| Aurinia Pharmaceuticals, Inc. | 614.86M |
| enGene Therapeutics, Inc. | 255.17M |
| Medicus Pharma Ltd. | -1.243M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.81M |
| Total Liabilities (Quarterly) | 0.9431M |